Interventions in the Acute Phase of Myocardial Infarction: 41 (Developments in Cardiovascular Medicine, 41) - Image 1

£76.42

Springer Interventions in the Acute Phase of Myocardial Infarction: 41 (Developments in Cardiovascular Medicine, 41)

Name: Interventions in the Acute Phase of Myocardial Infarction: 41 (Developments in Cardiovascular Medicine, 41)
Brand: Springer
Price: 76.42 GBP
Availability: InStock

Cardiovascular

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£76 today · all-time low £76 (Jun 2026) · usually £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 77 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £76 (42 days, 54.5%)

Price range: £76 - £78

Price levels: 3 different prices over 77 days

Description

In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is about a 20% chance of a North American male developing myocardial in farction before the age of 65. The in-hospital mortality still remains at ap proximately 10070-15070 and advances in pharmacologic and device therapy have allowed for the intensification of research in the treatment of patients with acute myocardial infarction. The following manuscripts represent the collective efforts of academic in vestigators in the United States and abroad as well as members of the phar maceutical industry, and the Food and Drug Administration to address the issues involved in interventions in the acute phase of myocardial infarction. State-of-the-art papers addressing important topics are followed by discus sion sections which have allowed participants to express their own viewpoints leading to a consensus opinion. The first part of this Symposium addresses the models of experimental myocardial infarction followed by the important issue of how one defines myocardial infarction size. The latter is extremely important to be certain that endpoints of therapeutic or device interventions are objective and reproducible. A detailed description of the pharmacological interventions to reduce myocardial infarction size as well as newer devices to effect mechanical and electrical disorders provide an up-to-date summary of current opinion.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461338212
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Publication Date: 13 October 2011
Listed Since: 21 December 2012

Barcode

No barcode data available

Springer Interventions in the Acute Phase of Myocardial Infarction: 41 (Developments in Cardiovascular Medicine, 41)

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Management of Myocardial Reperfusion Injury

Myocardial Damage: Early Detection by Novel Biochemical Markers: 205 (Developments in Cardiovascular Medicine, 205)

Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania: 88 (Developments in Cardiovascular Medicine, 88)

Acute Myocardial Infarction in Young Women: Understanding its Mechanisms and Management

Clinical Pharmacology of Antianginal Drugs: 76 (Handbook of Experimental Pharmacology, 76)

Lethal Arrhythmias Resulting from Myocardial Ischemia and Infarction: Proceedings of the Second Rappaport Symposium: 94 (Developments in Cardiovascular Medicine, 94)

Functional Aspects of the Normal, Hypertrophied, and Failing Heart: 42 (Developments in Cardiovascular Medicine, 42)

Complications of Percutaneous Coronary Intervention: The Survival Handbook

Coronary Angioplasty: A Controlled Model for Ischemia: 58 (Developments in Cardiovascular Medicine)

Pathophysiology of Severe Ischemic Myocardial Injury: 104 (Developments in Cardiovascular Medicine, 104)

Myocardial Injury: 161 (Advances in Experimental Medicine and Biology, 161)

Textbook of Cardiovascular Intervention

Regulation of Coronary Blood Flow

Cardiac Ischemia: From Injury to Protection: 4 (Basic Science for the Cardiologist, 4)

Cardiac Arrhythmias: New Therapeutic Drugs and Devices: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and ... (Developments in Cardiovascular Medicine, 47)

Analysis and Assessment of Cardiovascular Function

The Developing Heart: Clinical Implications of its Molecular Biology and Physiology

The Role of Immune Mechanisms in Cardiovascular Disease

Effectiveness of Ace Inhibitors & ARBs in Heart Disease Treatment (Cardiology Research and Clinical Developments)

Pathophysiology and Pharmacology of Heart Disease: Proceedings of the symposium held by the Indian section of the International Society for Heart ... in Cardiovascular Medicine, 102)

Aging Issues in Cardiology: 250 (Developments in Cardiovascular Medicine, 250)

Cardiac Allograft Rejection

Cardiovascular Nuclear Medicine and MRI: Quantitation and Clinical Applications: v. 128 (Developments in Cardiovascular Medicine)

Advances in Imaging Techniques in Ischemic Heart Disease: 171 (Developments in Cardiovascular Medicine, 171)